RxDoctor Payments Data

Jenna Bernstein, MD

Adult Reconstructive Orthopaedic Surgery · Trumbull, CTNPI 1689093775

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $217,059 of the $272,572 with a category attached, or 79.6%. 15 manufacturers reported payments, led by Medical Device Business Services, Inc. at 55.4% of the total. 2025 is the largest year on record at $81,603, 7.2 times the $11,344 reported in 2020.

$272,572in general payments, 2019–2025

Across 275 payments — averaging $991.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$151K
  • Smith+Nephew$105K
  • Depuy Synthes Products, Inc.$8K
  • Johnson & Johnson$3K
  • Brixton Biosciences, Inc.$2K
  • Stryker$873
  • plus $2K from 9 others
$12,474in research payments, 2019–2025

Across 6 payments — averaging $2079.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$12K

What the payments were for

  • Consulting fees$217,05980%
  • Speaking & faculty fees$10,9254%
  • Travel & lodging$24,0289%
  • Food & beverage$10,6434%
  • Education$9,9174%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$150,034
Medicare patients
255
Services billed
2,008

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib44$809
Methocarbamol67$470
Methylprednisolone60$405
Meloxicam199$350
Oxycodone Hcl39$237
Ibuprofen16$63
Amoxicillin46$40
Clindamycin Hcl26$32

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Trumbull

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →